PotentandselectiveERK5inhibitor;inhibitsEGFR-inducedERK5autophosphorylation(EC50=90nM)andERK5enzymaticactivity(IC50=162nM).Exhibitsatleast30-foldselectivityforERK5overLRRK2inacellbasedassay.AlsoselectiveforERK5overapanelofotherkinases.Orallybioavailable.
SoldunderlicensefromDana-FarberCancerInstitute.
ERK5-IN-1isalsoofferedaspartoftheTocriscreenPlusandTocriscreenKinaseInhibitorToolboxII.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Thefollowingdataisbasedontheproductmolecularweight638.8.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.